Autophagy function and dysfunction: Potential drugs as anti-cancer therapy

57Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

Abstract

Autophagy is a highly conserved catabolic and energy-generating process that facilitates the degradation of damaged organelles or intracellular components, providing cells with components for the synthesis of new ones. Autophagy acts as a quality control system, and has a pro-survival role. The imbalance of this process is associated with apoptosis, which is a “positive” and desired biological choice in some circumstances. Autophagy dysfunction is associated with several diseases, including neurodegenerative disorders, cardiomyopathy, diabetes, liver disease, autoimmune diseases, and cancer. Here, we provide an overview of the regulatory mechanisms underlying autophagy, with a particular focus on cancer and the autophagy-targeting drugs currently approved for use in the treatment of solid and non-solid malignancies.

Cite

CITATION STYLE

APA

Cuomo, F., Altucci, L., & Cobellis, G. (2019, October 1). Autophagy function and dysfunction: Potential drugs as anti-cancer therapy. Cancers. MDPI AG. https://doi.org/10.3390/cancers11101465

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free